Formyl Peptide Receptor as a Novel Therapeutic Target for Anxiety-Related Disorders

• Irene Gallo ,

  Contributed equally to this work with: Irene Gallo, Lorenza Rattazzi

  Affiliation William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom

  ⨯
• Lorenza Rattazzi ,

  Contributed equally to this work with: Irene Gallo, Lorenza Rattazzi

  Affiliation William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom

  ⨯
• Giuseppa Piras,

  Affiliation William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom

  ⨯
• Thomas Gobbetti,

  Affiliation William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom

  ⨯
• Elisabetta Panza,

  Affiliation Department of Experimental Pharmacology, University of Naples “Federico II”, Naples, Italy

  ⨯
• Mauro Perretti,

  Affiliation William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom

  ⨯
• Jeffrey W. Dalley ,

  ¶JD and FD are joint senior authors on this work.

  Affiliations Department of Psychology, University of Cambridge, Cambridge, United Kingdom, Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Fulvio D'Acquisto

  * E-mail: F.Dacquisto@qmul.ac.uk

  ¶JD and FD are joint senior authors on this work.

  Affiliation William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom

  ⨯